What is the Catalyst Edge convergence score for LLY?

As of 2026-09-18, LLY has a convergence score of 17 with conviction tier WATCH and 13 independent signals firing. Score is a weighted aggregate across SEC filings, insider activity, options flow, dark-pool prints, short-squeeze metrics, and macro regime.

How is LLY's score calculated?

Each signal contributes weighted points; weights are auto-tuned weekly against published outcome history. Full methodology + audit at https://catalystedgescanner.com/methodology/ and https://catalystedgescanner.com/trust/.

LLY — Catalyst score 17 (WATCH) · pharma

$LLY

pharma · convergence 17 · conviction WATCH

Convergence Score

Conviction

WATCH

Signals Firing

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $LLY?

LLY 17 WATCH pharma

Quantitative

Revenue (CY2026Q2): $22.97B (+47.7% YoY)
Net Income (CY2026Q2): $7.09B (+25.3% YoY)
Net Margin (CY2026Q2): 30.9%

Catalysts

Clinical trial milestone: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity
Clinical trial milestone: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Risks

Position-sizing discipline: Conviction WATCH (17 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

Squeeze unwind: Short interest can compress before retail catches the move — entry timing critical

Sympathy basket (cerebro)

ABBV via pharma r=+0.00 intra-sector (score 38)
GILD via pharma r=+0.00 intra-sector (score 35)
MRK via pharma r=+0.00 intra-sector (score 30)
JNJ via pharma r=+0.00 intra-sector (score 27)
XBI via pharma r=+0.00 intra-sector (score 23)
BMY via pharma r=+0.00 intra-sector (score 21)

Signals Firing

finra_shortclinicalmacroorphan_leancongressoge_execsec_fdaauto_setup_classifierauto_macro_13f_whalesauto_macro_eia_petroleumauto_macro_sec_proxy_fightauto_macro_term_premiumauto_macro_wiki_pageviews

Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Sympathy Basket

ABBVvia pharma · score 38
GILDvia pharma · score 35
MRKvia pharma · score 30
JNJvia pharma · score 27
XBIvia pharma · score 23
BMYvia pharma · score 21

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 48.9% of the time across 374 tracked calls. Baseline for everything else: 40.9%. That is a +8.0 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

Click Become a Founding Member below.

Pay $99 once — not monthly, not ever again.

You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

29 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment. Lifetime access. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →